Post job

Asklepios BioPharmaceutical's revenue is $115.0 million.

What is Asklepios BioPharmaceutical's revenue?

Asklepios BioPharmaceutical's annual revenue is $115.0M. Zippia's data science team found the following key financial metrics about Asklepios BioPharmaceutical after extensive research and analysis.
  • Asklepios BioPharmaceutical has 820 employees, and the revenue per employee ratio is $140,244.
  • Asklepios BioPharmaceutical peak revenue was $115.0M in 2024.

On this page

Peak revenue
$115.0M (2024)
Company peak revenue
Revenue / employee
$140,244
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$115.0M (2024)
Company peak revenue
Revenue / employee
$140,244
Company revenue / employee

Asklepios BioPharmaceutical financing

Asklepios BioPharmaceutical received early financing of $1.6M on 2004-01-01.

SeriesRound sizeDate
Grant$1.6M01/2004
Grant$2.5M12/2006
Private Equity$235M04/2019
Grant$2.4M09/2020

Asklepios BioPharmaceutical investors

InvestorsSecurity type
Muscular Dystrophy AssociationGrant
Muscular Dystrophy AssociationGrant
Vida Ventures LLCPrivate Equity
TPG Capital AsiaPrivate Equity
Scottish EnterpriseGrant

Asklepios BioPharmaceutical revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Asklepios BioPharmaceutical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Asklepios BioPharmaceutical. The employee data is based on information from people who have self-reported their past or current employments at Asklepios BioPharmaceutical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Asklepios BioPharmaceutical. The data presented on this page does not represent the view of Asklepios BioPharmaceutical and its employees or that of Zippia.

Asklepios BioPharmaceutical may also be known as or be related to ASKLEPIOS BIOPHARMACEUTICAL, Asklepios BioPharmaceutical, Asklepios BioPharmaceutical Inc, Asklepios BioPharmaceutical, Inc. and Asklepios BioPharmaceutical, Inc. - AskBio.